{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:43:50Z","timestamp":1791607430786,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s13555-021-00597-7","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T18:45:42Z","timestamp":1630694742000},"page":"1541-1549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Mast Cell Stabilizers in the Treatment of Rosacea: A Review of Existing and Emerging Therapies"],"prefix":"10.1007","volume":"11","author":[{"given":"Mark C.","family":"Marchitto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,2]]},"reference":[{"issue":"3","key":"597_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jaad.2004.03.030","volume":"51","author":"GH Crawford","year":"2004","unstructured":"Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51(3):327\u201341. https:\/\/doi.org\/10.1016\/j.jaad.2004.03.030 (quiz 342\u20134).","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"597_CR2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/bjd.16481","volume":"179","author":"L Gether","year":"2018","unstructured":"Gether L, Overgaard LK, Egeberg A, Thyssen JP. Incidence and prevalence of rosacea: a systematic review and meta-analysis. Br J Dermatol. 2018;179(2):282\u20139. https:\/\/doi.org\/10.1111\/bjd.16481.","journal-title":"Br J Dermatol"},{"issue":"4","key":"597_CR3","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/j.1365-2133.2011.10436.x","volume":"165","author":"M Augustin","year":"2011","unstructured":"Augustin M, Herberger K, Hintzen S, Heigel H, Franzke N, Sch\u00e4fer I. Prevalence of skin lesions and need for treatment in a cohort of 90 880 workers. Br J Dermatol. 2011;165(4):865\u201373. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10436.x.","journal-title":"Br J Dermatol"},{"issue":"1","key":"597_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaad.2009.04.024","volume":"63","author":"MA McAleer","year":"2010","unstructured":"McAleer MA, Fitzpatrick P, Powell FC. Papulopustular rosacea: prevalence and relationship to photodamage. J Am Acad Dermatol. 2010;63(1):33\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2009.04.024.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"597_CR5","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/ijd.13491","volume":"56","author":"LJ Rueda","year":"2017","unstructured":"Rueda LJ, Motta A, Pab\u00f3n JG, et al. Epidemiology of rosacea in Colombia. Int J Dermatol. 2017;56(5):510\u20133. https:\/\/doi.org\/10.1111\/ijd.13491.","journal-title":"Int J Dermatol"},{"issue":"3","key":"597_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1053\/sder.2001.27553","volume":"20","author":"JT Bamford","year":"2001","unstructured":"Bamford JT. Rosacea: current thoughts on origin. Semin Cutan Med Surg. 2001;20(3):199\u2013206. https:\/\/doi.org\/10.1053\/sder.2001.27553.","journal-title":"Semin Cutan Med Surg"},{"issue":"Suppl 4","key":"597_CR7","first-page":"S4","volume":"2","author":"AM Katz","year":"1998","unstructured":"Katz AM. Rosacea: epidemiology and pathogenesis. J Cutan Med Surg. 1998;2(Suppl 4):S4-10.","journal-title":"J Cutan Med Surg"},{"issue":"3","key":"597_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/jcp.2004.017210","volume":"58","author":"AS Janssens","year":"2005","unstructured":"Janssens AS, Heide R, den Hollander JC, Mulder PG, Tank B, Oranje AP. Mast cell distribution in normal adult skin. J Clin Pathol. 2005;58(3):285\u20139. https:\/\/doi.org\/10.1136\/jcp.2004.017210.","journal-title":"J Clin Pathol"},{"issue":"4 Pt 1","key":"597_CR9","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/0190-9622(90)70264-i","volume":"23","author":"MJ Rothe","year":"1990","unstructured":"Rothe MJ, Nowak M, Kerdel FA. The mast cell in health and disease. J Am Acad Dermatol. 1990;23(4 Pt 1):615\u201324. https:\/\/doi.org\/10.1016\/0190-9622(90)70264-i.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"597_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-4362.1995.tb04366.x","volume":"34","author":"S Weber","year":"1995","unstructured":"Weber S, Kr\u00fcger-Krasagakes S, Grabbe J, Zuberbier T, Czarnetzki BM. Mast cells. Int J Dermatol. 1995;34(1):1\u201310. https:\/\/doi.org\/10.1111\/j.1365-4362.1995.tb04366.x.","journal-title":"Int J Dermatol"},{"issue":"3","key":"597_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00403-007-0816-z","volume":"300","author":"K Aroni","year":"2008","unstructured":"Aroni K, Tsagroni E, Kavantzas N, Patsouris E, Ioannidis E. A study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process. Arch Dermatol Res. 2008;300(3):125\u201331. https:\/\/doi.org\/10.1007\/s00403-007-0816-z.","journal-title":"Arch Dermatol Res"},{"issue":"11","key":"597_CR12","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1038\/jid.2014.222","volume":"134","author":"Y Muto","year":"2014","unstructured":"Muto Y, Wang Z, Vanderberghe M, Two A, Gallo RL, Di Nardo A. Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea. J Invest Dermatol. 2014;134(11):2728\u201336. https:\/\/doi.org\/10.1038\/jid.2014.222.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"597_CR13","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1152\/physrev.1997.77.4.1033","volume":"77","author":"DD Metcalfe","year":"1997","unstructured":"Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev. 1997;77(4):1033\u201379. https:\/\/doi.org\/10.1152\/physrev.1997.77.4.1033.","journal-title":"Physiol Rev"},{"key":"597_CR14","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nm1616","volume":"13","author":"K Yamasaki","year":"2007","unstructured":"Yamasaki K, Di Nardo A, Bardan A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med. 2007;13:975\u201380. https:\/\/doi.org\/10.1038\/nm1616.","journal-title":"Nat Med"},{"issue":"5","key":"597_CR15","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.4049\/jimmunol.170.5.2274","volume":"170","author":"A Di Nardo","year":"2003","unstructured":"Di Nardo A, Vitiello A, Gallo RL. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol. 2003;170(5):2274\u20138. https:\/\/doi.org\/10.4049\/jimmunol.170.5.2274.","journal-title":"J Immunol"},{"issue":"5","key":"597_CR16","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jaad.2014.08.028","volume":"72","author":"AM Two","year":"2015","unstructured":"Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015;72(5):749\u201358. https:\/\/doi.org\/10.1016\/j.jaad.2014.08.028.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"597_CR17","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jaad.2014.08.027","volume":"72","author":"AM Two","year":"2015","unstructured":"Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part II. Topical and systemic therapies in the treatment of rosacea. J Am Acad Dermatol. 2015;72(5):761\u201370. https:\/\/doi.org\/10.1016\/j.jaad.2014.08.027 (quiz 771-2).","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"597_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.det.2017.11.001","volume":"36","author":"CS Ahn","year":"2018","unstructured":"Ahn CS, Huang WW. Rosacea pathogenesis. Dermatol Clin. 2018;36(2):81\u20136. https:\/\/doi.org\/10.1016\/j.det.2017.11.001.","journal-title":"Dermatol Clin"},{"issue":"Suppl A","key":"597_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s0954-6111(89)80245-8","volume":"83","author":"JA Kuzemko","year":"1989","unstructured":"Kuzemko JA. Twenty years of sodium cromoglycate treatment: a short review. Respir Med. 1989;83(Suppl A):11\u20134. https:\/\/doi.org\/10.1016\/s0954-6111(89)80245-8.","journal-title":"Respir Med"},{"issue":"5","key":"597_CR20","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/ACI.0000000000000473","volume":"18","author":"H Ben-Eli","year":"2018","unstructured":"Ben-Eli H, Solomon A. Topical antihistamines, mast cell stabilizers, and dual-action agents in ocular allergy: current trends. Curr Opin Allergy Clin Immunol. 2018;18(5):411\u20136. https:\/\/doi.org\/10.1097\/ACI.0000000000000473.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"597_CR21","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jaip.2019.02.002","volume":"7","author":"M Castells","year":"2019","unstructured":"Castells M, Butterfield J. Mast cell activation syndrome and mastocytosis: initial treatment options and long-term management. J Allergy Clin Immunol Pract. 2019;7(4):1097\u2013106. https:\/\/doi.org\/10.1016\/j.jaip.2019.02.002.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"597_CR22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1365-2133.2009.09516.x","volume":"162","author":"R Vieiraantos","year":"2010","unstructured":"Vieiraantos R, Magerl M, Martus P, et al. Topical sodium cromoglicate relieves allergen- and histamine-induced dermal pruritus. Br J Dermatol. 2010;162(3):674\u20136. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09516.x.","journal-title":"Br J Dermatol"},{"issue":"5","key":"597_CR23","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1053\/j.ajkd.2017.05.018","volume":"70","author":"E Simonsen","year":"2017","unstructured":"Simonsen E, Komenda P, Lerner B, et al. Treatment of uremic pruritus: a systematic review. Am J Kidney Dis. 2017;70(5):638\u201355. https:\/\/doi.org\/10.1053\/j.ajkd.2017.05.018.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"597_CR24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3109\/09546634.2014.933766","volume":"26","author":"MT Stevens","year":"2015","unstructured":"Stevens MT, Edwards AM. The effect of 4% sodium cromoglicate cutaneous emulsion compared to vehicle in atopic dermatitis in children\u2013A meta-analysis of total SCORAD scores. J Dermatolog Treat. 2015;26(3):284\u201390. https:\/\/doi.org\/10.3109\/09546634.2014.933766.","journal-title":"J Dermatolog Treat"},{"issue":"10","key":"597_CR25","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1177\/0961203318781008","volume":"27","author":"FR Spinelli","year":"2018","unstructured":"Spinelli FR, Moscarelli E, Ceccarelli F, et al. Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort. Lupus. 2018;27(10):1616\u201323. https:\/\/doi.org\/10.1177\/0961203318781008.","journal-title":"Lupus"},{"issue":"3","key":"597_CR26","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1562\/0031-8655(1999)069<0282:psoad>2.3.co;2","volume":"69","author":"AG Motten","year":"1999","unstructured":"Motten AG, Mart\u00ednez LJ, Holt N, et al. Photophysical studies on antimalarial drugs. Photochem Photobiol. 1999;69(3):282\u20137. https:\/\/doi.org\/10.1562\/0031-8655(1999)069%3c0282:psoad%3e2.3.co;2.","journal-title":"Photochem Photobiol"},{"issue":"Suppl 1","key":"597_CR27","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1177\/0961203396005001031","volume":"5","author":"R Fox","year":"1996","unstructured":"Fox R. Anti-malarial drugs: possible mechanisms of action in autoimmune disease and prospects for drug development. Lupus. 1996;5(Suppl 1):S4-10. https:\/\/doi.org\/10.1177\/0961203396005001031.","journal-title":"Lupus"},{"key":"597_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.clim.2018.07.004","volume":"194","author":"E Espinosa","year":"2018","unstructured":"Espinosa E, Valitutti S, Laroche M, et al. Hydroxychloroquine as a novel therapeutic approach in mast cell activation diseases. Clin Immunol. 2018;194:75\u20139. https:\/\/doi.org\/10.1016\/j.clim.2018.07.004.","journal-title":"Clin Immunol"},{"key":"597_CR29","doi-asserted-by":"publisher","first-page":"106178","DOI":"10.1016\/j.intimp.2019.106178","volume":"79","author":"J Li","year":"2020","unstructured":"Li J, Yuan X, Tang Y, et al. Hydroxychloroquine is a novel therapeutic approach for rosacea. Int Immunopharmacol. 2020;79:106178. https:\/\/doi.org\/10.1016\/j.intimp.2019.106178.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"597_CR30","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jaad.2020.05.050","volume":"84","author":"B Wang","year":"2021","unstructured":"Wang B, Yuan X, Huang X, et al. Efficacy and safety of hydroxychloroquine for treatment of patients with rosacea: a multicenter, randomized, double-blind, double-dummy, pilot study. J Am Acad Dermatol. 2021;84(2):543\u20135. https:\/\/doi.org\/10.1016\/j.jaad.2020.05.050.","journal-title":"J Am Acad Dermatol"},{"key":"597_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev-med-043015-123453","volume":"14","author":"J An","year":"2017","unstructured":"An J, Minie M, Sasaki T, Woodward JJ, Elkon KB. Antimalarial drugs as immune modulators: new mechanisms for old drugs. Annu Rev Med. 2017;14:317\u201330. https:\/\/doi.org\/10.1146\/annurev-med-043015-123453.","journal-title":"Annu Rev Med"},{"issue":"3","key":"597_CR32","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/s1043-6618(03)00107-5","volume":"48","author":"HH Chen","year":"2003","unstructured":"Chen HH, Zhou HJ, Fang X. Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro. Pharmacol Res. 2003;48(3):231\u20136. https:\/\/doi.org\/10.1016\/s1043-6618(03)00107-5.","journal-title":"Pharmacol Res"},{"key":"597_CR33","doi-asserted-by":"publisher","first-page":"109181","DOI":"10.1016\/j.biopha.2019.109181","volume":"117","author":"X Yuan","year":"2019","unstructured":"Yuan X, Li J, Li Y, et al. Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea. Biomed Pharmacother. 2019;117:109181. https:\/\/doi.org\/10.1016\/j.biopha.2019.109181.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"597_CR34","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1080\/09546634.2019.1610549","volume":"30","author":"GJ Wang","year":"2019","unstructured":"Wang GJ, Gao XY, Wu Y, et al. Evaluation of the efficacy and tolerance of artemether emulsion for the treatment of papulopustular rosacea: a randomized pilot study. J Dermatol Treat. 2019;30(8):809\u201312. https:\/\/doi.org\/10.1080\/09546634.2019.1610549.","journal-title":"J Dermatol Treat"},{"issue":"2","key":"597_CR35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/all.12077","volume":"68","author":"C Cheng","year":"2013","unstructured":"Cheng C, Ng DS, Chan TK, et al. Anti-allergic action of anti-malarial drug artesunate in experimental mast cell-mediated anaphylactic models. Allergy. 2013;68(2):195\u2013203. https:\/\/doi.org\/10.1111\/all.12077.","journal-title":"Allergy"},{"issue":"3","key":"597_CR36","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1365-2133.2011.10716.x","volume":"166","author":"J Fowler","year":"2012","unstructured":"Fowler J, Jarratt M, Moore A, et al. Brimonidine Phase II Study Group Once-daily topical brimonidine tartrate gel 0\u00b75% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies. Br J Dermatol. 2012;166(3):633\u201341. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10716.x.","journal-title":"Br J Dermatol"},{"issue":"6","key":"597_CR37","first-page":"699","volume":"13","author":"JM Jackson","year":"2014","unstructured":"Jackson JM, Fowler J, Moore A, et al. Improvement in facial erythema within 30 minutes of initial application of brimonidine tartrate in patients with rosacea. J Drugs Dermatol. 2014;13(6):699\u2013704.","journal-title":"J Drugs Dermatol"},{"issue":"11","key":"597_CR38","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1111\/exd.13381","volume":"26","author":"M Kim","year":"2017","unstructured":"Kim M, Kim J, Jeong SW, Jo H, Woo YR, Park HJ. Inhibition of mast cell infiltration in an LL-37-induced rosacea mouse model using topical brimonidine tartrate 0.33% gel. Exp Dermatol. 2017;26(11):1143\u20135. https:\/\/doi.org\/10.1111\/exd.13381.","journal-title":"Exp Dermatol"},{"issue":"10","key":"597_CR39","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3390\/toxins4100913","volume":"4","author":"S Chen","year":"2012","unstructured":"Chen S. Clinical uses of botulinum neurotoxins: current indications, limitations and future developments. Toxins (Basel). 2012;4(10):913\u201339. https:\/\/doi.org\/10.3390\/toxins4100913.","journal-title":"Toxins (Basel)"},{"issue":"4","key":"597_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000368773","volume":"230","author":"KY Park","year":"2015","unstructured":"Park KY, Hyun MY, Jeong SY, Kim BJ, Kim MN, Hong CK. Botulinum toxin for the treatment of refractory erythema and flushing of rosacea. Dermatology. 2015;230(4):299\u2013301. https:\/\/doi.org\/10.1159\/000368773.","journal-title":"Dermatology"},{"issue":"12","key":"597_CR41","first-page":"e76","volume":"11","author":"SH Dayan","year":"2012","unstructured":"Dayan SH, Pritzker RN, Arkins JP. A new treatment regimen for rosacea: onabotulinumtoxinA. J Drugs Dermatol. 2012;11(12):e76\u20139.","journal-title":"J Drugs Dermatol"},{"key":"597_CR42","doi-asserted-by":"publisher","unstructured":"Bharti J, Sonthalia S, Jakhar D. Mesotherapy with botulinum toxin for the treatment of refractory vascular and papulopustular rosacea. J Am Acad Dermatol. 2018;19:S0190\u20139622(18)30808\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2018.05.014.","DOI":"10.1016\/j.jaad.2018.05.014"},{"issue":"1","key":"597_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/dsu.12057","volume":"39","author":"TT Khan","year":"2013","unstructured":"Khan TT, Herne K, Dayan SH, Woodward JA. Facial blanching due to neurotoxins: proposed mechanisms. Dermatol Surg. 2013;39(1):24\u20139. https:\/\/doi.org\/10.1111\/dsu.12057.","journal-title":"Dermatol Surg"},{"key":"597_CR44","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.burns.2012.07.031","volume":"39","author":"TH Park","year":"2013","unstructured":"Park TH. The effects of botulinum toxin A on mast cell activity: preliminary results. Burns. 2013;39:816\u20137. https:\/\/doi.org\/10.1016\/j.burns.2012.07.031.","journal-title":"Burns"},{"issue":"4","key":"597_CR45","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/toxins10040134","volume":"10","author":"R Ramachandran","year":"2018","unstructured":"Ramachandran R, Marino MJ, Paul S, et al. A study and review of effects of botulinum toxins on mast cell dependent and independent pruritus. Toxins (Basel). 2018;10(4):134. https:\/\/doi.org\/10.3390\/toxins10040134.","journal-title":"Toxins (Basel)."},{"issue":"1","key":"597_CR46","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jdermsci.2018.12.004","volume":"93","author":"JE Choi","year":"2019","unstructured":"Choi JE, Werbel T, Wang Z, Wu CC, Yaksh TL, Di Nardo A. Botulinum toxin blocks mast cells and prevents rosacea like inflammation. J Dermatol Sci. 2019;93(1):58\u201364. https:\/\/doi.org\/10.1016\/j.jdermsci.2018.12.004.","journal-title":"J Dermatol Sci"},{"key":"597_CR47","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3389\/fmed.2019.00324","volume":"6","author":"L Wang","year":"2020","unstructured":"Wang L, Wang YJ, Hao D, Wen X, Du D, He G, Jiang X. The theranostics role of mast cells in the pathophysiology of rosacea. Front Med (Lausanne). 2020;6:324. https:\/\/doi.org\/10.3389\/fmed.2019.00324.","journal-title":"Front Med (Lausanne)"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-021-00597-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-021-00597-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-021-00597-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T14:04:10Z","timestamp":1633010650000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-021-00597-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,2]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["597"],"URL":"https:\/\/doi.org\/10.1007\/s13555-021-00597-7","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,2]]},"assertion":[{"value":"16 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}